XX2KXP9Monitoring of Interstitial Fluid Volume, Sub-Epidermal Moisture using Electrical Biocapacitance, External Approach, New Technology Group 9
- Billable / Specific Code
XX2KXP9 is a billable ICD-10-PCS procedure code for Monitoring of Interstitial Fluid Volume, Sub-Epidermal Moisture using Electrical Biocapacitance, External Approach, New Technology Group 9. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Monitoring involves determining the level of a physiological or physical function repetitively over a period of time. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Measurement and monitoring, NEC.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | X | Physiological Systems |
| 3 | Operation | 2 | Monitoring |
| 4 | BodyPart | K | Subcutaneous Tissue |
| 5 | Approach | X | External |
| 6 | Device/Substance/Technology | P | Interstitial Fluid Volume, Sub-Epidermal Moisture using Electrical Biocapacitance |
| 7 | Qualifier | 9 | New Technology Group 9 |
Clinical Classification (CCSR)
AHRQ groups XX2KXP9 into these clinical categories.
Similar Procedure Codes
Questions About XX2KXP9
Is XX2KXP9 a billable code?
Yes. XX2KXP9 is a complete seven-character ICD-10-PCS code, specific enough to report Monitoring of Interstitial Fluid Volume, Sub-Epidermal Moisture using Electrical Biocapacitance, External Approach, New Technology Group 9 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in XX2KXP9 mean?
XX2KXP9 breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character X is the Body System (Physiological Systems); the 3rd character 2 is the Operation (Monitoring); the 4th character K is the BodyPart (Subcutaneous Tissue); the 5th character X is the Approach (External); the 6th character P is the Device/Substance/Technology (Interstitial Fluid Volume, Sub-Epidermal Moisture using Electrical Biocapacitance); the 7th character 9 is the Qualifier (New Technology Group 9).
